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SUMMARY 
 
Specific association of tissue transglutaminase (tTG) with matrix fibronectin results in 
the formation of an extracellular complex (tTG-FN) with distinct adhesive and pro-
survival characteristics.  tTG-FN supports RGD-independent cell adhesion of different 
cell types and the formation of distinctive RhoA-dependent focal adhesions following 
inhibition of integrin function by competitive RGD peptides and function blocking anti-
integrin antibodies α5β1. Association of tTG with its binding site on the 70 kda amino-
terminal FN fragment does not support this cell adhesion process, which seems to involve 
the entire FN molecule. RGD-independent cell adhesion to tTG-FN does not require 
transamidating activity, is mediated by the binding of tTG to cell-surface heparan sulfate 
chains,  is dependent on the function of protein kinase Cα (PKCα) and leads to activation 
of the cell survival focal adhesion kinase (FAK). The tTG-FN complex can maintain cell 
viability of tTG-null mouse dermal fibroblasts when apoptosis is induced by inhibition of 
RGD-dependent adhesion (anoikis), suggesting an extracellular survival role for tTG. We 
propose a novel RGD-independent cell adhesion mechanism that promotes cell survival 
when the anti-apoptotic role mediated by RGD-dependent integrin function is reduced as 
in tissue injury, which is consistent with the externalisation and binding of tTG to 
fibronectin following cell damage/stress. 
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INTRODUCTION 
 
Subtle changes in the extracellular matrix (ECM) complexity/tissue architecture may be 
crucial for the regulation of the apoptotic machinery leading to anoikis (1, 2). Such a 
process occurs during tissue injury when the composition and integrity of the ECM are 
altered in several significant ways (3). A central component of the ECM, which regulates 
adhesion-dependent survival signalling, is the adhesive glycoprotein fibronectin (FN) (4). 
FN binds to cell-surface matrix receptors, primarily the α5β1 integrins, through the 
ArgGlyAsp (RGD) cell-binding site within the Type III10 domain. The importance of the 
RGD cell binding domain in adhesion-mediated cell survival has been demonstrated by 
employing synthetic peptides containing the RGD motif, which induce apoptosis in many 
cell types, by acting as competitive inhibitors of FN-integrin interaction and activators of 
caspase 3 (5, 6). A comparable scenario may occur in wounding and inflammatory 
conditions, whereby fragmentation of FN, can lead to detachment-induced apoptosis (7, 
5). However, the RGD cell-binding domain of FN is not sufficient in isolation to regulate 
cell survival, which must be sustained by other critical FN domains such as the C-
terminal heparin binding domain (HepII) (7, 8), known to synergistically interact with 
heparan sulfate proteoglycans (HSPG) receptors and integrin α4β1 (9). Evidence is also 
accumulating to suggest that changes in the molecular structure and composition of the 
FN matrix may provide new signals to regulate cell shape, migration and proliferation. 
Alterations to the conformation of FN either by multimerization (10) or heterotypic 
association with other matrix molecules (11) could reveal biologically active neo-
epitopes, which regulate cell responses via the induction of cytoskeleton assembly (12). 
Modulation of the FN matrix may therefore also be fundamental in the regulation of 
adhesion-related apoptosis. 
One protein which binds with high affinity specialised FN domains and modulates the 
function of FN is tissue-type transglutaminase (tTG, TG-2) (13, 10, 14). tTG is a 
multifunctional protein implicated in diverse normal and pathological processes (15) but 
more specifically is regarded as an important component of cell/tissue defence in 
response to cell damage and stress (16, 17). tTG differs from the other transglutaminases 
in that the transamidase active site is integrated with a GTP binding/hydrolysis site, 
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which negatively regulates the transamidation activity by structurally blocking the active 
site (18). Another peculiarity of tTG is its externalisation into the ECM via a non 
Golgi/ER route, through a mechanism which appears to depend on its active-state 
conformation (19) and an intact FN binding site in the 28 kd amino-terminal sandwich 
region (20, 21).  Matrix deposition of tTG increases in situations of tissue damage and 
cellular stress and results in the immobilisation of tTG on matrix FN (16, 17, 22, 20), 
which in turn protects tTG from matrix degradation (23). Consistent with these findings 
is the observation that guinea pig liver tTG forms specific complexes with human plasma 
FN and it appears as a globular protein bound to the N-terminal portion of FN interacting 
either with the Type I4-I5 motif (24) or with a sequence within the gelatin-binding domain 
of FN (I6-II1-II2-I7-I8-I9) (13).  
The involvement of tTG in the adhesion of multiple cell types is now consolidated (25, 
26), however the molecular mechanism and its physiological significance remain 
controversial. It has been proposed that tTG enhances cell adhesion through matrix 
remodelling, via protein crosslinking (10, 26), however recent findings suggest that tTG 
involvement in cell-matrix interactions is independent from its transamidation activity 
(27, 28, 19). Cell-surface tTG might act as an adhesion co-receptor of integrins β1 and β3 
by mediating cell adhesion to the gelatin binding domain of FN (27) or, conversely, act as 
an independent adhesion protein, by specific binding to α4β1 and α9β1 integrins (28). 
In the current study we have explored the involvement of tTG in FN-mediated cell 
survival, starting with the hypothesis that the ECM function of tTG is strictly dependent 
on its association with FN, and that tTG and FN reciprocally modulate each others 
functions following complex formation.  We report that FN-bound tTG supports a novel 
RGD-independent cell adhesion process, which is mediated by the direct binding of tTG 
to the cell surface through a mechanism that is critically dependent on cell-surface 
heparan sulfate and activation of protein kinase Cα (PKCα). We describe that FN-bound 
tTG, but not FN can rescue tTG-deficient mouse dermal fibroblasts from apoptosis 
induced by inhibition of RGD-dependent cell adhesion (anoikis), with maintenance of 
cell viability.  Our findings suggest that matrix FN with bound tTG is functionally 
distinct from either protein acting in isolation and suggest a novel RGD-independent 
pathway which may be important in cell survival under conditions of cell damage/stress. 
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EXPERIMENTAL PROCEDURES 
 
Reagents and antibodies 
Mouse monoclonal antibodies included anti-integrin β1 (JB1A) and α5 (PID6) 
(Chemicon), vinculin, tubulin (Sigma-Aldrich), tTG (Cub74) (NeoMarkers). Rabbit 
polyclonal antibodies included anti-human fibronectin (Sigma-Aldrich) and anti-human 
phospho(Tyr397)-FAK (Upstate Biotechnology).  The tTG inhibitor R283 (19) was 
synthesised by R. Saint and I. Coutts, Nottingham Trent University. Purified guinea pig 
liver tTG was either obtained by Sigma-Aldrich or purified according to Leblanc et al 
(1999) (29). Human plasma FN and FN proteolytic fragments, GTPγ-S, and synthetic 
RGD specific peptides (GRGDTP and GRGDSP) were from Sigma-Aldrich, control 
RAD peptide (GRADSP) from Calbiochem.  Heparitinase (EC4.2.2.8) was from  Sigma-
Aldrich, and chondroitinaseABC (protease-free) from Seikagaku Corporation. The PKCα 
inhibitor GO6976 was from Calbiochem.  
 
Cell lines  
Primary human osteoblasts (HOB) were provided by S. Downes (University of 
Nottingham, UK)  and maintained in Dulbecco’s modified Eagle’s medium (DMEM) as 
we previously described (30). Swiss 3T3 albino fibroblasts were obtained from American 
Type Culture Collection and maintained in DMEM supplemented with 10%(v/v) foetal 
calf serum (FCS), 2 mM glutamine, and penicillin/streptomycin (100 U/ml and 100 
µg/ml, respectively). Transfected Swiss 3T3 fibroblasts, displaying inducible expression 
of tTG (clone TG3), were cultured and induced as described by Verderio et al (1998), 
(22). Primary mouse dermal fibroblasts (MDF) were isolated from the skin of tTG-
deficient (MDF-TG-/-) and wild type (MDF-TG+/+) 9-months old mice and maintained 
as described by De Laurenzi and Melino (2001), (31). 
 
Immobilisation of TG on FN and amino-terminal FN fragments  
96-well plates were coated with human plasma FN  (5 µg/ml) or with the 70 kd (42 
µg/ml), 45 kd (54 µg/ml), and 30 kd (54 µg/ml) proteolytic fragments of FN in 50 mM 
Tris-HCl, pH 7.4, 50 µl/well, by incubation at 4 °C for approximately 15 h. 
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Concentrations of FN and FN fragments were optimal to saturate tissue culture plastic 
(TCP), as measured by an ELISA-based assay with polyclonal anti-FN antibody (1/5000) 
followed by peroxidase-labelled anti-rabbit IgG (1/5000). FN fragments were in a 30-, 
60- and 90-fold stoichiometric excess, respectively, of control FN. For tTG 
immobilisation, the FN solution was removed, the wells were washed once in 50 mM 
Tris-HCl, pH 7.4, and then incubated with purified guinea pig liver tTG  (20 µg/ml) in 
phosphate-buffered saline (PBS) containing 2 mM EDTA , 100 µl/well. After 1 h at 37 
°C, the tTG solution was removed and wells were washed once in 50 mM Tris-HCl, pH 
7.4, and once in serum-free culture medium before cell seeding. In some experiments FN 
coated plates were blocked with 3%(w/v) lipid milk protein (Marvel) in PBS at 37 °C for 
30 min and then washed twice with 50 mM Tris-HC1, pH 7.4, prior to tTG 
immobilisation.  The presence of tTG immobilised on FN was confirmed by an ELISA-
type assay using Cub74 as we previously described (26). The transamidating activity of 
the immobilised tTG was determined by the incorporation of biotinylated cadaverine into 
FN as previously described (26) and compared with the activity of free tTG standard. 
Data are expressed as absorbance 450nm with 5 mM Ca2+ in the reaction buffer minus 
background absorbance values with 5 mM EDTA.  
 
Cell adhesion assay 
Exponentially growing cells were detached using 0.25%(w/v) trypsin in 5 mM EDTA, 
collected into medium containing a ~7%(v/v) FCS, washed twice with medium without 
FCS and then plated onto 96-well plates (2×104 cells/well), coated with FN or FN 
fragments, with and without immobilised tTG.  After a maximum of 20 min incubation 
(to minimise the secretion of any endogenous protein) at 37 °C in a 5% CO2 atmosphere, 
cells were fixed in 3.7%(w/v) paraformaldehyde (PFM) in PBS, permeabilised in 
0.1%(v/v) Triton X-100 in PBS and stained with May Grunwald and Giemsa stain (26). 
In some cases cells were pre-treated for 15 h with 1 mM cycloheximide before plating, to 
rule out any effects of endogenous secreted adhesion molecules. Digital images of 3 non-
overlapping fields covering the central portion of each well were captured using a video 
digital camera (Olympus DP10) and examined using the Image Analysis programme 
Scion Image (National Institute of Health, USA). At least 9 images of separate fields per 
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sample were examined for a total of at least 400 cells in the FN control. The number of 
attached cell particles in each field was measured by “thresholding” and “particle 
analysis” and the spread cells by “density slicing”. 
 
Cytoskeletal staining 
Actin stress fibres were visualised using fluorescein isothiocyanate (FITC)-labelled 
phalloidin and focal adhesions by staining for vinculin. Cells were seeded in 0.79 cm2 
wells of chamber slides (8×104 cells /well) previously coated with FN and tTG-FN and 
allowed to adhere for ~20 min. Cells were fixed using 3.7%(w/v) PFM in PBS and 
permeabilised in 0.1%(v/v) TritonX-100 in PBS. For  actin stress fibres, cells were then 
blocked in PBS buffer supplemented with 5%(w/v) dry milk and then incubated with 
FITC-labelled phalloidin (20 µg/ml) in blocking buffer. For localisation of vinculin, cells 
were blocked in PBS buffer containing 3%(w/v) bovine serum albumin (BSA) and then 
incubated with mouse monoclonal anti-vinculin antibody (1:100) in blocking buffer. 
Bound antibody was revealed by incubation with rabbit anti-mouse IgG-FITC (1:100) 
(Dako) in blocking buffer. Coverslips were mounted with Vectashield mountant 
containing propidium iodide (Vector Laboratories) and examined by laser confocal 
microscopy using a Leica TCSNT system (Leica Lasertechnik). Consecutive scanning 
sections (~2 µm) from the upper to the bottom attachment site of cells were overlaid as an 
extended focus image and imaged cells (from at least 8 random fields, at least 100 cells in 
FN control) were scored for actin stress fiber formation with the aid of the Leica TCSNT 
(version 1.5-451) image processing menu.  
 
Inhibition of integrin-mediated cell adhesion 
Cells in suspension (2×105 cells/ml) were incubated with GRGDTP synthetic peptide 
(32) (50 µg/ml, ~75 µM, 100 µg/ml ~150 µM, or 200 µg/ml ~300 µM). Some 
experiments were reproduced using the FN-prototype GRGDSP peptide. Alternatively, 
cells in suspension (2×105 cells/ml) were incubated with function blocking anti-integrin 
antibodies (JB1A, 40 µg/ml and P1D6, 30 µg/ml). All incubations were performed in 
serum-free medium at 37 °C for 10 min after that cells were seeded in the presence of 
either the competitive RGD peptides or the anti-integrin antibodies.  
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Cell treatment with C3 exotranferase 
Clostridium botulinum C3 exotransferase (Biomol) (20 µg/ml) was incubated with 
lipofectamine (100 µg/ml) (Life Technologies) in DMEM at 22 °C for 1 h after that the 
complex was diluted 10 times in DMEM and added to duplicate 18-h old cell monolayers 
(~80% confluent) in serum-free medium. After 2 h the medium was removed, cells  
allowed to recover for ~30 min in serum-containing DMEM and then seeded in 0.79 cm2-
wells of chamber slides (45×103 cells/well). 
 
Quantification of anoikis and measurement of cell viability 
For fluorochrome labelling of DNA strand breaks, 6×105 cells were seeded in duplicate in 
9.6 cm2-wells pre-coated with FN or tTG-FN in the presence or absence of RGD peptide.  
After 15 h incubation at 37 °C in a 5% CO2 atmosphere, all cells (adhered and 
nonadhered) were collected, washed twice in PBS , resuspended at the final concentration 
of 1.2×107 cells/ml and fixed in suspension by addition of one volume of 4%(w/v) PFM 
in PBS.  Cells were then permeabilised in 0.1%(v/v)TritonX-100 in 0.1%(w/v) sodium 
citrate buffer, for 2 min on ice (to minimise loss of fragmented DNA). Cells were 
labelled with terminal deoxynucleotidyl transferase (TdT) and FITC-dUTP, using a 
TUNEL kit according to the manufacturer (Roche).  The fluorescence intensity was 
measured by flow cytometry using a Beckman Coulter EPICS XL.  Cells were collected 
and data stored and analysed using the software SYSTEM II and WinMDI2.8.  DNA 
fragmentation was also detected by in situ analysis of nuclei following TUNEL, by 
confocal fluorescent microscopy.  Cells found in suspension were fixed and labelled in 
triplicate on 0.79 cm2-wells of glass slides (~5 x104 cells/well).  For quantification, the 
Leica LCS software was used to acquire 3 random images per well for a total of 9 images 
per experimental sample using a fixed protocol (with constant photo-multiplier tube and 
section-depth setting).  Data are expressed as mean number of apoptotic cells per well.  
Cell viability was assessed by a colorimetric assay based on the metabolism of the 
tetrazolium salt XTT (Roche), after an incubation period of 4 h with XTT.  Data are 
expressed as absorbance values at 492nm after subtraction of values at 690nm. 
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Statistics 
Data are expressed as mean ±SD and represent one of at least 3 separate experiments 
undertaken in triplicate, unless stated otherwise. Differences between data sets were 
determined by the Student’s t-test (two-tailed distribution, two-sample equal variance). 
Differences described as significant in the text correspond to p<0.05. 
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RESULTS 
 
Tissue transglutaminase bound to FN supports RGD independent-cell adhesion of 
different cell types 
Previous work using fluorescent microscopy and immunogold electron microscopy 
demonstrated a close association of tTG with FN at the cell surface/pericellular matrix 
(22, 20), consistent with the in vitro specific binding of the enzyme with human plasma 
FN (24, 13). To investigate how tTG in complex with FN affects FN cell adhesion, we 
first bound purified guinea pig liver tTG to human plasma FN coated onto tissue culture 
plastic (TCP).  EDTA was included in the reaction to inhibit  tTG transamidating activity. 
Measurement of binding by an ELISA-type assay showed that FN, immobilised at the 
saturating concentration of 5 µg/ml, bound a saturating amount of tTG when incubated 
with 20 µg/ml free tTG (Fig. 1 A). Using this initial matrix model of immobilised FN 
with bound tTG (tTG-FN), the contribution tTG to FN cell adhesion was examined by 
inhibiting integrin-mediated RGD-dependent cell adhesion with competitive 
concentrations of soluble RGD peptides. Human osteoblast-like cells (HOB) were 
selected as the initial cell model since they preferentially adhere on FN in vitro, 
demonstrate an enhanced spread morphology on biomaterials coated with tTG-FN (33) 
and are characterised by a well defined pattern of integrin cell-surface receptors, 
consisting mainly of RGD-binding β1 subunit paired with α1, α2, α3, α5 and αV subunits 
(34). In the absence of RGD peptide, attachment to tTG-FN was comparable to FN (Fig. 
1 B, upper), although cell spreading appeared to be enhanced on tTG-FN (Fig. 1 B, 
lower).  At 50 and 100 µg/ml RGD peptide, attachment on FN was significantly reduced 
(typically to 30-50% of control values on FN) (Fig. 1 B, upper), but attachment to tTG-
FN was not significantly inhibited at these same RGD peptide concentrations. Cell 
attachment to tTG-FN in the presence of 100 µg/ml RGD peptide was 85-95% of control 
cell attachment to FN without RGD peptide. Only at 200 µg/ml, was cell attachment to 
tTG-FN significantly lower in comparison to control FN without RGD peptide. At this 
higher concentration, the RGD peptide may in part act non-specifically, since the control 
RAD peptide also led to a small reduction in cell attachment at 200 µg/ml (Fig. 1 B, 
upper inset). Incubation of cells with RGD peptide, significantly reduced cell spreading 
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on FN (Fig. 1 B, lower), typically to 10-50% of control value at 100 µg/ml RGD peptide, 
but as for cell attachment, cell spreading was only partially reduced on tTG-FN at 50 and 
100 µg/ml RGD peptide (usually to 65-85% of control values on FN).  Swiss 3T3 
fibroblasts displayed a comparable response to HOB cells on the tTG-FN complex. 
Attachment (Fig. 1 C upper) and spreading (Fig. 1 C, lower) of Swiss 3T3 fibroblasts to 
FN was significantly decreased with excess RGD peptide, in a more sensitive way than in 
osteoblasts (typically to 25-35% of control at 100 µg/ml RGD peptide), but was restored 
to control levels when cells were seeded onto tTG-FN at 50 and 100 µg/ml RGD peptide. 
An epithelial-like cell line (ECV304) also adhered more efficiently on tTG-FN than FN 
in the presence of excess RGD peptide (Fig. Suppl. 1).  When cells were seeded onto 
TCP coated with tTG without prior immobilisation of FN, cell attachment was found to 
be negligible at concentrations ranging from 20 to 50 µg/ml of tTG, in the absence or 
presence of competitive RGD peptide (Fig. 1 C).  Plates were coated with saturating 
amounts of FN and blocking of FN-coated wells with 3% non-fat milk protein prior to 
tTG immobilisation did not affect RGD-independent cell attachment and spreading 
supported by the tTG-FN matrix formed in the absence of blocking (data not shown).  
These findings clearly indicate that the complex of tTG bound to FN is the essential 
component for the RGD-independent cell adhesion to occur.  Association of purified tTG 
to free human plasma FN in solution prior to immobilisation onto TCP, with the 
suggested stoichiometry of approximately 2:1 (24), also led to a matrix able to 
significantly support RGD-independent cell adhesion and spreading (which respectively 
were 80±1.4 and 98±3.9 of control FN, in a typical experiment with 100 µg/ml RGD 
peptide).  Cells pre-treated with cycloheximide, to rule out secretion of endogenous 
adhesion molecules, were still capable of RGD-independent cell attachment on tTG-FN 
(data not shown). Together these data show that binding of tTG to FN supports a novel 
RGD-independent pathway. 
 
tTG immobilisation on amino-terminal FN fragments is not sufficient to mediate 
RGD-independent adhesion of osteoblast-like cells 
Since tTG is known to bind to FN at a domain within the 70 kd amino-terminal fragment 
(24, 13) we explored whether association of tTG to N-terminal FN peptides was 
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sufficient to support RGD-independent cell adhesion. tTG was immobilised on the 70 kd 
(matrix assembly, heparin and gelatin binding), 45 kd (gelatin-binding) and 30 kd (first 
type I repeats, matrix assembly, heparin binding) amino-terminal FN peptides. Detection 
of the relative levels of tTG by ELISA showed that incubation of the FN fragments with 
20 µg/ml tTG resulted in saturating levels of tTG immobilised on all fragments (Fig. 2 
A). Cell adhesion of HOB cells to the different FN fragments alone or in complex with 
tTG was compared. On the 70 kd fragment alone, both cell attachment and spreading in 
the absence of RGD peptide were ~80% the values obtained on FN (Fig. 2 B upper and 
lower, respectively), however on the 45 kd and 30 kd fragments cell attachment and cell 
spreading were only ~10% and ~5% of control FN, respectively.  In the presence of RGD 
peptide, cell attachment and spreading values on the 70 kd fragment were significantly 
inhibited by ~40% (Fig. 2 B upper and lower, respectively). This data agrees with 
previous findings that the amino-terminal of FN binds the integrin α5β1 in cross-
competition with the RGD peptide (Hocking et al 2000). Immobilisation of tTG on the 70 
kd fragment unlike FN did not induce RGD-independent cell attachment and spreading 
but led to further deterioration of cell adhesion (Fig. 2 B). Yet tTG did not enhance cell 
adhesion to the 70 kd fragment even in the absence of the RGD peptide. Furthermore, 
tTG did not improve cell adhesion on the 45 kd and 30 kd fragments, which remained at 
negligible levels (Fig. 2 B).  These results indicate that adhesion of HOB cells to the 
amino-terminal 45 kd and 30 kd FN fragments, which contain putative tTG binding sites 
(13, 24), is negligible regardless of the binding of tTG and that tTG binding to the 70 kd 
peptide is not sufficient to sustain RGD-independent cell adhesion. 
 
RGD-independent cell adhesion to FN with immobilised tTG promotes formation of 
unique focal adhesion structures 
Formation of actin stress fibers in the presence of integrin-binding RGD peptide in 
response to tTG-FN was analysed by confocal laser scanning microscopy utilizing FITC-
phalloidin.  HOB cells adhered to FN did not show organised stress fibers following 
RGD peptide treatment (Fig. 3 A, c), compared to non-treated cells (Fig. 3 A, a), which 
exhibited a flat morphology and extensive actin stress fibers. In contrast, most of the cells 
seeded on tTG-FN were spread and had organised actin stress fibers despite the RGD 
 12 
Pr
e-P
rin
t
peptide (Fig. 3 A, d), however the actin fibers formed were shorter and less organised 
than those assembled in control cells adhered to FN in the absence of RGD peptide (Fig. 
3 A, a). Without RGD peptide, actin stress fibres appeared more dense and well-formed 
in response to tTG-FN than FN (Fig. 3 A, b and a, respectively), confirming that 
immobilised tTG enhances cell spreading (see Fig. 1 B).  Staining for vinculin indicated 
the absence of punctate characteristic focal contacts of FN-adhered cells (Fig. 3 A, e) in 
the RGD-treated cells adhered to FN (Fig. 3 A, g) but not in those adhered to tTG-FN 
(Fig. 3 A, h). Relative measurement of the formed actin stress fibres (Fig. 3 A, graph) 
confirmed that the RGD peptide did not affect the formation of focal adhesions in cells 
plated on tTG-FN, although it significantly affected the quality of the actin 
reorganisation, as shown by fluorescence microscopy (Fig. 3 A, d).  Treatment of cells 
with the function blocking anti-integrin β1 (JBIA) and, to a lesser extent α5 antibody 
(PID6), led to a large decrease of actin stress fibers on FN (Fig. 3 B, b and c, 
respectively), compared to cells incubated with non-specific IgG (Fig. 3 B, a). In contrast, 
on tTG-FN, cells incubated with the anti-integrin antibodies appeared to maintain a 
network of actin stress fibers (Fig. 3 B, e and f), although less elaborated and dense than 
in control cells treated with IgGs (Fig. 3 B, d). Comparison of the number of formed actin 
stress fibers (Fig. 3 B, graph) statistically confirmed these observations that tTG-FN leads 
to the formation of integrin β1 and α5 independent actin filaments even though more 
rudimental than in the absence of inhibition.  RGD-independent adhesion of cells to tTG-
FN was dependent on GTPase RhoA, since inhibition of RhoA activity by botulinum 
toxin C3 exotransferase almost completely blocked RGD-independent assembly of actin 
stress fibers in response to tTG-FN (Fig. 3 C). 
 
tTG cross-linking activity is not required to support RGD-independent cell adhesion   
We next assayed the transamidating activity of FN-bound tTG to establish its potential 
role in the described RGD independent cell adhesion process. The activity of tTG once 
bound to FN was negligible when measured in cell culture medium DMEM, which 
contains an activating concentration of Ca2+ (1.9 mM), and was not changed by addition 
of further Ca2+, but was significantly boosted by pre-incubation of tTG with DTT prior to 
immobilisation on FN (Fig. 4 A), as described (26). Hence, under the conditions used 
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FN-bound tTG is not active in the presence of cell culture medium, unless its cysteine 
residues, particularly the active-site Cys277, are kept in a reduced state. The 
transamidation-independent role of tTG in the RGD-independent cell adhesion process 
was further confirmed by utilizing the irreversible inhibitor R283, a 2-[(2-
oxopropyl)thio]imidazolium derivative (19). HOB cells were incubated with R283 and 
plated on a tTG-FN matrix pre-treated with R283, in the absence or presence of RGD 
peptide. Under these conditions the activity of the immobilised tTG, is completely 
blocked by the inhibitor (Fig. 4 C). The low tTG activity found at the HOB cell surface 
(30) is also inhibited to negligible values by equal concentrations of R283 (unpublished 
data). Cell adhesion on FN bound to inactivated tTG was not significantly different to 
cell adhesion on FN bound to tTG not treated with the inhibitor, with or without pre-
treatment of cells with RGD peptide, and it was typically twice cell adhesion on FN in 
the presence of RGD peptide (Fig. 4 B; cell attachment, upper and cell spreading, lower).  
These data clearly indicate that FN-bound tTG does not require its transamidating activity 
to promote RGD-independent cell adhesion. 
 
Evidence for the importance of FN-associated tTG and its calcium-induced 
conformation in cell-surface recognition 
To assess the importance of tTG in cell-surface interaction, FN-bound tTG was blocked 
by using the monoclonal anti-tTG antibody Cub74, in conditions that fully preserved the 
availability of FN in this complex. This was demonstrated by the unchanged recognition 
of FN by anti-FN polyclonal antibody after treatment of tTG-FN with either Cub74 or 
control IgG (Fig. 5 B). Obstruction of tTG by Cub74 completely abolished the RGD-
independent cell adhesion mediated by tTG-FN (Fig. 5 A; cell attachment, upper and cell 
spreading, lower), suggesting a direct role for FN-associated tTG in the RGD-
independent binding to cells.   tTG can assume two conformations, depending on whether 
it is bound to GTP/GDP or Ca2+ (18). In the extracellular environment, tTG is likely to 
assume the Ca2+-induced open structure. Incubation of FN-bound tTG with the non 
hydrolysable GTP-γS (1 mM), significantly reduced the RGD-independent cell 
attachment and spreading mediated by tTG-FN (Fig. 5 C, upper and lower, respectively). 
Since incubation of tTG with GTP-γS did not significantly alter the level of tTG bound to 
 14 
Pr
e-P
rin
t
FN (Fig. 5 D), our results suggest that RGD-independent cell adhesion to tTG-FN 
critically depends on the calcium-mediated tertiary structure of tTG. 
 
Role of cell-surface heparan sulfate in RGD-independent cell adhesion and 
signalling via tTG-FN 
To explore the possibility that cell adhesion to tTG-FN may be mediated by a cell-surface 
proteoglycan, HOB cells were treated with glysosaminoglycan-degrading enzymes. 
Degradation of cell-surface heparan sulfate chains with heparitinase (15 mU/ml) led to a 
reduced cell attachment to FN (~70% of control values) (Fig. 6 A, upper), as expected 
given the importance of cell-membrane heparan sulfate proteoglycans (HSPG) in the 
adhesion of osteoblast-like cells (34). It also led to complete abolishment of RGD-
independent cell attachment and spreading on tTG-FN (Fig. 6 A, upper and lower 
respectively). In contrast, equal concentrations of protease-free chondroitinase ABC had 
no significant effect on cell adhesion to FN, did not significantly alter RGD-independent 
cell spreading on tTG-FN (Fig. 6 A, lower) and only marginally affected cell attachment 
(Fig. 6 A, upper). These results demonstrate that RGD-independent cell adhesion to tTG-
FN critically depends on cell-surface heparan sulfate and suggest the involvement of cell-
surface heparan sulfate proteoglycans (HSPG) and not chondroitin sulfate proteoglycans 
in this process.  Syndecan-4 is the only known HSPG that is a widespread component of 
focal adhesions and downstream signalling specifically involves PKCα (35). Cells were 
therefore treated with the selective PKCα inhibitor G06976 (36) prior to and during the 
cell adhesion experiments. Following G06976 incubation, a significant inhibition (~30%) 
of both attachment and spreading on FN (Fig. 6 B upper and lower respectively) with 
control RAD and RGD peptide occurred, which was comparable to the inhibition of 
attachment following heparitinase (Fig. 6 A, upper). Moreover, the PKCα inhibitor 
drastically reduced RGD-independent attachment (over 90%) and spreading (~85%) 
mediated by the tTG-FN complex (Fig. 6 B), indicating that cell adhesion mediated by 
tTG-FN critically depends on PKCα activity. This finding also hints at syndecan-4 as the 
likely HSPG responsible for binding the tTG-FN complex. 
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RGD-independent adhesion in response to tTG-FN enhances tyrosine 
phosphorylation of FAK 
Having shown that tTG-FN transmits signals via a heparan sulfate receptor leading to cell 
spreading and that this process depends on the activity of PKCα, we next examined 
whether the attachment to tTG-FN led to activation of FAK. Tyrosine phosphorylation of 
FAK in cells plated on FN and treated with RGD peptide was decreased to ~25% that 
found in control cells plated on FN and pre-incubated with control RAD peptide (Fig. 7). 
In response to tTG-FN instead, the level of FAK phosphorylation in the presence of RGD 
peptide was found to be ~60% the level of both control cells on FN or tTG-FN. This data 
shows that the RGD-independent cell adhesion mediated by tTG-FN enhances tyrosine 
phosphorylation of FAK and as such implies FAK as one of the intracellular signalling 
mediators of tTG-FN.  
 
RGD-independent cell adhesion can be mediated by a physiological matrix of cell-
assembled FN and cell-secreted tTG 
We have previously shown that increased expression of tTG within cells results in an 
increased export of the enzyme into the extracellular matrix (22, 20, 37, 19).  Such a 
phenomenon has been observed during cell stress and following cell wounding (16, 17).  
In order to produce such a cell model, conditioned matrices of cell-assembled FN with 
different bound levels of cell-secreted tTG were obtained from a long-term culture of a 
transfected fibroblast cell line (Swiss 3T3-TG3), capable of tetracycline (tet) regulatable 
expression of tTG (22).  Cells were then removed from both conditioned matrices, and in 
their place wild-type Swiss 3T3 fibroblasts were seeded and allowed to adhere in the 
presence of increasing concentrations of RGD peptide. The FN-rich ECM with increased 
amounts of cell-secreted tTG (ECM/TG3-tet) (Fig. 8 B). supported significantly higher 
RGD-independent cell attachment at each RGD peptide concentration, compared to the 
ECM with background levels of tTG (ECM/TG3+tet) (Fig. 8 A). RGD-independent cell 
attachment on the lower tTG containing ECM/TG3+tet could be significantly increased 
by immobilisation of purified tTG on this matrix (ECM/TG3+tet plus tTG) (Fig. 8 A). 
However, at low levels of RGD peptide, cell attachment was still more effective on the 
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ECM containing cell-secreted tTG (ECM/TG3-tet) than on the ECM containing added 
tTG (ECM/tTG3+tet plus tTG). This was despite higher levels of tTG present following 
exogenous addition of TG (data not shown), suggesting that cell-secreted tTG is better 
presented to the cell surface. The ECM deposited by cells with increased levels of tTG 
(ECM/TG3-tet) showed no significant difference in tTG enzymatic activity above 
background (ECM/TG3+tet) in culture medium, unless in the presence of reducing agent 
(Fig. 8 C). This is consistent with the idea that tTG activity is gradually downregulated 
once sequestered in the oxidising extracellular environment. 
 
FN-bound tTG rescues primary dermal fibroblasts from anoikis 
A potential physiological function of the tTG-mediated RGD-independent cell adhesion 
is the protection from apoptosis (anoikis) triggered by inhibition of RGD-dependent 
adhesion. This phenomenon could occur in tissue injury when changes in the ECM 
composition lead to reduction of RGD-dependent cell adhesion (8, 5) and the increased 
externalisation and binding of tTG to the FN matrix in response to wounding (16, 17) 
may result in an alternative adhesion-dependent survival pathway.  Non confluent 
cultures of mouse dermal fibroblasts devoid of tTG (MDF-TG-/-) were plated on FN or 
tTG-FN, and incubated with RGD peptide under serum-free conditions. After ~15 h, the 
majority of the RGD-treated cells plated on FN were detached and displayed 
morphological signs of apoptosis. The extent of endonucleolysis was measured by 
fluorescent labelling of DNA strand breaks using TUNEL and quantified by flow 
cytometry (Fig. 9 A). After incubation with the RGD peptide ~24% of the total 
fibroblasts grown on FN were apoptotic (black histogram) compared to only ~2.6% of 
fibroblasts grown on tTG-FN (blue histogram), which behaved similarly to control cells 
grown on FN in the absence of RGD peptide (green histogram). These data were 
corroborated by in situ fluorescent labelling of nuclei undertaken on the detached cells in 
suspension, which was visualised and scored by confocal microscopy (Fig. 9 B). At 15 h 
exposure to the RGD peptide, a significantly lower number of apoptotic cells were found 
in the culture fluid of cells grown on tTG-FN compared to FN. The level of apoptosis 
upon incubation on tTG-FN was comparable to that found in the culture medium of 
control cells on FN without the RGD peptide (Fig. 9 B). After 30 h incubation in the 
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absence of serum, nuclear fragmentation appeared to increase not only in cells grown 
with RGD peptide but also in cells grown on FN without RGD peptide, thus limiting our 
investigations to ~15 h time-period (Fig. 9 B). We next assayed the viability of MDF-TG-
/- in response to tTG-FN (Fig. 9 C). Cell viability on FN was significantly decreased after 
15-h exposure to RGD peptide, compared to control RAD peptide (Fig. 9 C), in 
agreement with the level of total apoptotic cell death measured in the same conditions by 
flow cytometry (Fig. 9 A). In contrast, cell viability on tTG-FN was not substantially 
altered by incubation with RGD peptide and it was found to be ~30% higher than on FN 
(Fig. 9 C), indicating that attachment to tTG-FN mediates RGD-independent cell 
survival. 
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DISCUSSION 
 
The impact of tTG, a well characterised FN-associating protein and modulator of the FN 
matrix on FN-mediated cell survival has never been investigated (38).  Whereas previous 
studies have analysed the roles of tTG by modulating its expression (25, 26, 39, 22), in 
the present study we have developed a model that allows us to characterise cellular 
responses to a tTG-rich FN matrix, thus mimicking physio/pathological conditions in 
vivo. Support for our model comes from findings that tTG is not only externalised under 
normal physiological conditions but it is also upregulated, exported and deposited into 
the ECM in response to tissue trauma following cellular damage, inflammation or cell 
stress (40, 16, 17), where it either binds FN fibrils directly or plasma FN (20, 22, 24), 
which is then deposited in the damaged area.  Hence a complex of tTG and FN, formed 
as a result of matrix alterations during tissue injury, may provide a mechanism to ensure 
adhesion-mediated cell survival in wound-repair in response to the reduction or loss of 
RGD-dependent cell adhesion (8, 5).  
To test this hypothesis, we initially examined the function of the tTG-FN complex in cell-
matrix interactions whereby we inhibited the “classical” adhesion-mediated survival 
pathway dependent on the interaction of the FNIII10 RGD cell-binding site with α5β1 
integrins.  A human osteoblast-like cell line served as the initial cell model since 
osteoblasts secrete both FN and tTG (34, 30, 41), are subject to continuous matrix 
remodelling processes during their differentiation, are characterised by a well defined and 
simple pattern of integrin cell surface receptors, mainly β1, and make use of RGD-
independent pathways in the attachment to the ECM (34).  We demonstrate that the loss 
of cell-matrix interaction by inhibition of RGD-dependent integrin function, can be 
largely re-established upon seeding of cells on either FN with associated tTG or a more 
physiological matrix of cell-assembled FN containing cell-secreted tTG. This latter form 
of tTG-FN matrix is thought to be the most important form present in vivo as in tissues, 
FN is present as an insoluble fibrillar matrix to which tTG is closely associated (22, 20). 
Restoration of cell adhesion by tTG-FN following RGD inhibition was also found in 
mouse Swiss 3T3 fibroblasts and in the epithelial-like cells ECV-304, suggesting that 
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many cell types can use the RGD-independent cell-adhesion pathway mediated by tTG-
FN. 
We demonstrate that cell adhesion to tTG-FN is not linked to modification of FN  by 
calcium-dependent transamidation. This finding is consistent with recent observations 
indicating a transamidating-independent role for tTG in cell-matrix interactions (27, 28, 
19). Moreover we show that when tTG is complexed with FN it becomes catalytically 
inactive unless kept in a reduced state. Indeed, previous work has described that tTG 
sequestration by FN leads to downregulation of enzymatic activity on large-size protein 
substrates (24). In contrast, in situ tTG activity demonstrated with small-size fluorescent 
primary amine substrate has clearly shown that tTG is catalytically active while present at 
the cell surface (22). tTG may modify FN by its intrinsic protein disulfide isomerase 
(PDI) activity, which has been recently ascribed to it (42). However, since GTP-binding 
to tTG affects the adhesion function of FN-bound tTG but does not affect the PDI activity 
of tTG this possibility seems unlikely.  
The outside-in signalling induced by the RGD-independent cell adhesion to tTG-FN 
appears to result by direct interaction of tTG with the cell surface, since the blocking of 
tTG accessibility by a monoclonal antibody greatly reduces this process. The calcium-
mediated tertiary structure of tTG is also required, suggesting that crucial cell binding 
sites might be exposed when tTG assumes the calcium-induced open conformation. 
However, the simple binding of 20 µg/ml tTG to either tissue culture plastic or the gelatin 
binding domain of FN, which contains the tTG binding site (13), does not enhance cell 
adhesion, which is indeed equally negligible regardless of the presence of tTG, in 
contrast to what has been previously reported (28, 27). We also found that tTG binding to 
the 70 kd amino-terminal fragment of FN, which can support cell adhesion and includes 
the tTG binding site, is not sufficient to sustain tTG-mediated RGD-independent cell 
adhesion. This leads us to conclude that the RGD-independent adhesion to tTG-FN is 
both tTG and FN dependent, with the amino-terminal of FN required to support tTG 
binding and the carboxy-terminal of FN and/or cryptic epitopes outside the FNIII9-10 
domains, essential to sustain the RGD-independent pathway.  
Our data also suggest that the RGD-independent cell adhesion to tTG-FN is integrin-
independent or, alternatively, the integrin must be in partnership with some other 
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receptor(s). This observation is supported by the finding that tTG-mediated focal 
adhesions still formed in the presence of function blocking anti-integrin antibodies β1 and 
α5, which cause conformational inactivation of the receptor, thus preventing outside in 
signalling (43). Under these conditions the actin stress fibers formed appeared less 
complex than normal, nevertheless the cytoarchitecture was sufficient for the formation 
of distinct RGD-independent focal adhesions, which are mediated by GTPase RhoA and 
induce FAK tyrosine phosphorylation. Therefore, modulation of matrix FN by tTG adds 
to the increasing number of non-integrin mediated stimuli which enhance FAK activity 
through actin polymerisation (44). The possibility that tTG-FN may mediate RGD-
independent cell adhesion through the α4β1-induced RGD-independent pathway is also 
unlikely since low or negligible levels of α4 subunit are generally expressed in 
osteoblasts (34). Moreover, matrix binding to α4β1 does not generate actin stress fibers 
(45). Although tTG association with integrins is documented, our data suggest that it is 
more likely that the cell function induced by tTG-FN results from the binding to non 
integrin receptors. Given the high affinity binding of tTG for heparin (46), a possible 
candidate receptor for tTG-FN is that belonging to the class of HSPG (35). Treatment of 
HOB cells with heparitinase but not chondroitinase ABC, greatly diminished the RGD-
independent adhesion in response to tTG-FN, suggesting that cell surface HSPG may 
mediate RGD-independent cell adhesion to tTG-FN. The C-terminal HepII domain of FN 
is responsible for the synergistic interaction of FN with cell surface heparan sulfate and 
integrins and this interaction is essential for optimal cell adhesion and critical for 
sustained cell survival (7, 35). Association of tTG with FN could induce RGD-
independent cell adhesion by reinforcing HSPG-mediated adhesion, through a dual 
mechanism involving the binding of tTG to cell surface HSPG and increased exposure of 
the C-terminal heparin-binding domain of FN, which critically depends on FN structure 
(9).  The increased cell spreading observed in osteoblasts and Swiss 3T3 fibroblasts in 
early cell adhesion to tTG-FN also in the absence of integrin inhibition, suggests that 
HSPG receptors are not fully occupied when cells are normally seeded on a FN matrix 
and that increased binding occurs in response to tTG-FN. Downstream signalling from 
syndecan-4, the only HSPG that is a widespread component of focal adhesion, 
specifically results in hyperactivation of PKCα and  activation of both RhoA and FAK 
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(7, 35). Our results suggest that RGD-independent cell adhesion mediated by tTG-FN 
requires PKCα activity since the compound Gö6976, which is the only inhibitor available 
that shows specificity for PKCα (36), blocks this process. Our data also show that the 
function of FN-bound tTG depends on RhoA activation and is linked to activation of the 
cell survival kinase FAK (1, 44). 
Moreover, in preliminary investigations using a Raf-1 null 3T3 like immortalised 
fibroblast cell line (47) we could demonstrate that the RGD-independent cell adhesion 
pathway by tTG-FN is not functional in this cell line (unpublished data).  This suggests 
that the Raf-1 protein, whose main function is anti apoptotic (47), may be a key 
component in the signalling pathway mediated by tTG-FN.  The observation that a tTG-
FN matrix can rescue tTG-null primary dermal fibroblasts from anoikis with maintenance 
of cell viability is therefore consistent with its activation of intracellular survival 
mediators. Importantly, it shows that the survival role of tTG is essentially extracellular 
and not intracellular as recently suggested by Antonyak et al (2001) (48), following 
upregulation of tTG by retinoic acid.   
It is now accepted that RGD-mediated cell adhesion is not sufficient in isolation to 
maintain cell survival. For sustained survival cells need to interact with “complex” ECMs 
via integrin and non-integrin receptors, such as cell surface proteoglycans (7). 
Interestingly like tTG, increased expression of syndecan-4 is also found at sites of tissue 
injury (35). The work presented here indicates that binding of tTG to FN represents one 
additional survival signal by inducing heparan-sulfate receptors-mediated cell adhesion, 
which can either act in synergy or in alterative to integrin RGD-dependent cell adhesion 
at sites of tissue injury. 
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ABBREVIATIONS 
 
The abbreviations used are:  ECM, extracellular matrix;  FN, fibronectin;  HSPG, heparan 
sulfate proteoglycans;  tTG, tissue transglutaminase;  PKCα, protein kinase Cα;  HOB, 
human osteoblasts;  DMEM, Dulbecco’s modified Eagle’s medium;  FCS, fetal calf 
serum;  MDF, mouse dermal fibroblasts; TCP, tissue culture plastic;  ELISA, enzyme-
linked immunosorbent assay;  PBS, phosphate-buffered saline;  PFM, paraformaldehyde;  
FITC, fluorescein isothiocyanate;  BSA, bovine serum albumine;  tet, tetracycline;  
TUNEL, TdT-mediated dUTP nick end labeling;  TdT, terminal deoxynucleotidyl 
transferase. 
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FIGURE LEGENDS 
 
Figure 1 
tTG bound to FN but not tissue culture plastic supports RGD-independent cell 
adhesion.  
(A) Relative levels of tTG bound to coated FN at increasing concentrations of free tTG.  
Data are expressed as mean ± SD absorbance at 450nm and represent one typical 
experiment undertaken in triplicate. Background absorbance (in the range of 0.02-0.15) 
was subtracted from data. The level of tTG bound to fibronectin (FN) after incubation 
with 20 µg/ml free tTG is significantly different from the level after incubation with 10 
µg/ml, but not 30-50 µg/ml tTG. The level of tTG bound to tissue culture plastic (TCP) 
represents the positive experimental control.  (B) RGD-independent cell adhesion of 
HOB cells and (C) Swiss 3T3 fibroblasts in response to tTG-FN. Cell attachment (upper 
graphs in B and C) and cell spreading (lower graphs in B and C) on FN and tTG-FN were 
assessed 20 min after seeding cells pre-incubated with increasing concentrations of RGD 
synthetic peptide (0-200 µg/ml) (RGD 0-200), as described in the “Experimental 
Procedures”.  Insets in B and C show cell attachment (upper insets) and spreading (lower 
insets) on FN when cells were pre-incubated with equivalent concentrations of control 
RAD peptide (RAD 0-200).  Each point represents the mean number of attached cells 
(cell attachment) or the mean percentage of spread cells (cell spreading) ±SD. Data are 
expressed as percentage of control values on FN, which represents 100% and represent 
one of at least 3 separate experiments performed in triplicate.  Mean attachment values 
±SD on FN control were 306±53 (HOB) and 166±3 (Swiss 3T3) in upper graphs, 246±13 
(HOB) and 155±14 (Swiss 3T3) in upper insets; mean percentage values of spread cells 
on FN control were 78±5 (HOB) and 88±1 (Swiss 3T3) in lower graphs and 82±2 (HOB) 
and 86±3 (Swiss 3T3) in lower insets; total cells analysed in control sample were ~900 
(HOB) and ~500 (Swiss 3T3).  (D) Comparison of HOB cell attachment to TCP with 
increasing concentrations of bound tTG (20-50 µg/ml) and TCP with bound FN (5 µg/ml) 
in complex with tTG (20-50 µg/ml). Cell attachment was assessed and expressed as 
described above (RGD peptide was 100 µg/ml). Mean attachment values ±SD on FN 
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control were 214±22. Total cells analysed in control sample were ~700.  RGD-
independent cell attachment to TCP with bound tTG did not significantly differ from cell 
attachment to TCP at any tTG concentration. 
 
Figure 2 
tTG immobilisation on amino-terminal FN fragments is not sufficient to mediate 
RGD-independent cell adhesion. 
(A) Relative levels of tTG bound to the amino-terminal FN fragments (70 kd, 45 kd, and 
30 kd) immobilised on TCP, at increasing concentrations of free tTG. Data are expressed 
as mean ± SD absorbance at 450nm and are from a typical experiment performed in 
triplicate. The level of tTG bound to each fragment after incubation with 20 µg/ml tTG 
was not significantly different from the level bound using 30 µg/ml. (B) Assessment of 
cell adhesion in response to tTG bound to amino-terminal FN fragments. Wells were pre-
coated with amino-terminal FN fragments and in half of the wells 20 µg/ml tTG was  
immobilised upon them  (TG-70, TG-45, TG-30). Cell attachment (B upper) and cell 
spreading (B lower) of HOB cells pre-incubated with RGD peptide (100 µg/ml) (+RGD) 
or DMEM (-RGD) were assessed and data expressed as described in legend to Fig. 1. In 
B upper, ordinate represents mean cell attachment expressed as mean percentage of 
control attachment to FN (which represents 100%) ±SD of 3 independent experiments 
undertaken in triplicate (mean attachment value ±SD on FN in the 3 experiments was 
406±72, 370±49, 465±51; total cells analysed in control samples were respectively 
~1200, ~1100, ~1400). In B lower, ordinate represents the mean percentage of spread 
cells, expressed as mean percentage of control spreading on FN ±SD of 3 independent 
experiments undertaken in triplicate (mean percentage of spreading ±SD on FN in the 3 
experiment was 87±1, 91±1, 88±7). 
 
Figure 3 
Confocal laser fluorescence microscopy of RGD-independent actin cytoskeleton 
organisation and focal adhesion in response to tTG-FN. 
(A) Visualisation of actin stress fibers and focal adhesions in the presence of RGD 
peptide. Cells were seeded as in legend to Fig. 1 and the indicated cells pre-treated with 
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RGD peptide (100 µg/ml) (RGD). Actin stress fibres and focal adhesions were revealed 
as described in the “Experimental Procedures”. Images were acquired by confocal laser 
fluorescence microscopy and cells in random fields (at least 100 cells in FN control) were 
scored for actin stress fiber formation as outlined in the “Experimental Procedures”. Data 
shown in the histogram are from a representative experiment. Ordinate represents the 
mean percentage of cells with formed actin stress fibers expressed as percentage of 
control values on FN. Mean ±SD percentage of cells with stress fibers formed on control 
FN was 74±2. Arrows point at tTG-FN mediated stress fibers with and without RGD 
peptide. Bars 10 µM.  (B) Actin stress fibers in the presence of function blocking anti-
integrin α5 and β1 antibodies. HOB cells in suspension were pre-incubated with anti-
integrin antibodies P1D6 (α5) and JB1A (β1) or control mouse IgGs (IgG) before seeding 
on either FN or tTG-FN as described in A. At least 200 cells in FN/IgG control were 
scored. Mean percentage value of cells with actin fibers formed on control FN ±SD was 
49±8.4 in B upper and 53±7.8 in B lower graph. Bars 10 µM  (C) Relative measurement 
of actin stress fibers following pre-incubation with the RhoA inhibitor C3 exotransferase. 
Monolayers of HOB cells were loaded with C3 exotransferase (C3), or lipofectin only 
(Lpf), as described in the “Experimental Procedures” and then seeded as described in A. 
At least 250 cells in FN/Lpf control were scored. Mean percentage value of cells with 
actin fibers formed on control FN ±SD was 63±5.  
 
Figure 4 
tTG cross-linking activity is not required to support RGD-independent cell adhesion 
to tTG-FN. 
(A) The activity of FN-bound tTG (TG-FN) was measured by incorporation of 
biotinylated cadaverine into FN in either culture medium DMEM (DM), or DMEM with 
5 mM Ca2+ (DM-Ca2+) or DMEM supplemented with 5 mM DTT (DM-DTT).  Values 
represent the mean ± SD absorbance at 450nm of one typical experiment undertaken in 
triplicate.  (B) Cell adhesion to tTG-FN following inactivation of tTG. The tTG-FN 
matrix was incubated with the tTG irreversible inhibitor R283 (100 µM), and then 
utilised as adhesive substrate for HOB cells, further supplemented with the same 
concentration of R283. In controls, identically treated cells were seeded on tTG-FN 
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without R283 treatment. Where indicated, cells were pre-incubated with RGD peptide 
(100 µg/ml). Cells were examined for cell attachment (B upper) and cell spreading (B 
lower) and data expressed as percentage of control values on FN as in Fig. 1. Mean 
attachment value on FN control ±SD, 373±36 in B upper; mean percentage value of 
spread cells ±SD on FN control, 89±6 in B lower; total cells analysed in control sample, 
~1100. Data shown are from a representative experiment undertaken in triplicate.  (C) 
Inhibition of the cross-linking activity of FN-bound tTG (TG-FN) and tTG free in 
solution (fTG) by 100 µM R283, when measured as described in A, in buffer containing 
DTT. Values represent the mean ± SD of a representative experiment undertaken in 
triplicate.  
 
Figure 5 
RGD-independent cell adhesion to FN-bound tTG depends on tTG accessibility and 
GTP-mediated conformational change. 
(A) FN-bound tTG was blocked by incubation with Cub74 (40 µg/ml) for 1 h at 37 °C in 
PBS with 2 mM EDTA using mouse IgG1k as control antibody. Following pre-
incubation with RGD peptide, cells were seeded on the tTG-FN matrix. Adhered cells 
were examined for cell attachment (A upper) and cell spreading (A lower) and data 
expressed as in legend to Fig. 1. Mean attachment value ±SD on FN control, 229±13 in A 
upper; mean percentage value of spread cells ±SD on FN control, 93±2 in A lower; total 
cells analysed in control sample, ~700. Data are from a typical experiment undertaken in 
triplicate. (B) Availability of FN, detected as described in the “Experimental Procedures”, 
after blocking the tTG-FN matrix by Cub74 and IgG1k. Values represent the mean ± SD 
absorbance at 450nm of 4 replicates from a typical experiment.  (C) HOB cells in 
suspension, pre-incubated with RGD peptide (100 µg/ml) as indicated, were seeded in the 
presence of 1 mM GTP-γS on FN-bound tTG, pre-incubated with 1mM GTP-γS in PBS 
for 10 min at room temperature. Adhered cells were examined for cell attachment (C 
upper) and cell spreading (C lower) with and without inactivation of tTG by GTP-γS and 
data expressed as in legend to Fig. 1. Mean attachment value ±SD on FN control, 
294±98.32 in C upper; mean percentage value of spread cells ±SD on FN control, 84.9±4 
in C lower; total cells analysed in control sample, ~800. Data are from a typical 
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experiment undertaken in triplicate. (D) Relative levels of tTG that bind FN in the 
presence of 1 mM GTP-γS, in conditions identical to C above. tTG was detected by an 
ELISA-type assay described in the “Experimental Procedures”. Values represent the 
mean ± SD absorbance at 450nm of 4 replicates from a representative experiment. 
 
Figure 6 
RGD-independent cell adhesion to tTG-FN is dependent on cell surface heparan 
sulfate and PKCα activity 
(A) HOB cells in suspension (2x105 cell/ml) were pre-treated with 15 mU/ml heparitinase 
or 15 mU/ml protease-free chondroitinase ABC in serum-free medium for 1 h at 37 °C  
before evaluating cell attachment (upper) and cell spreading (lower) in the presence of 
RGD or RAD peptide (100µg/ml).  Data are produced and expressed as in legend to Fig. 
1 and represent percentage of control values on FN from one of 3 separate experiments. 
Mean attachment values ±SD on FN control without peptide treatment (not shown), 
140±16; mean percentage values of spread cells on FN control, 89±2; total cells analysed 
in control sample, ~420.  (B) Monolayers of sub-confluent HOB cells were serum-starved 
for 12 h and then incubated in serum-free DMEM medium supplemented with the PKCα 
inhibitor Gö6976 (5 µM, dissolved in DMSO) for 1 h or with an equal volume of DMSO 
only. Cells were then harvested and analysed for cell attachment (upper) and spreading 
(lower) on FN and tTG-FN. Data, expressed as percentage of control values on FN, are 
from one of 3 separate experiments. Mean attachment and spread cell values ±SD on FN 
control without peptide (not shown), 197±8 and 83±4, respectively; total cells analysed in 
control sample, ~590.   
 
Figure 7 
RGD-independent adhesion to tTG-FN promotes tyrosine phosphorylation of FAK.  
Lysates of HOB cells grown in the presence of RGD or RAD control peptide (100 µg/ml)  
on FN, tTG-FN or control BSA-coated TCP, were western blotted and then 
immunoprobed with phospho(Tyr397)-FAK antibody followed by peroxidase conjugate 
anti-rabbit IgG (FAK-PY), as described in the “Experimental Procedures”. After 
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stripping, blots were re-probed to reveal control protein tubulin (Tub). Density of bands 
was quantified by scanning densitometry, and phospho-FAK bands normalised against 
values for tubulin bands (relative FAK-PY). Results from one of 3 typical experiments 
are shown.  
 
Figure 8 
A physiological matrix of FN and cell-secreted tTG supports RGD-independent cell 
adhesion of Swiss 3T3 fibroblasts. 
(A) Swiss 3T3-TG3 cells were grown on TCP either in the absence of tet, to induce the 
expression of tTG and deposit a ECM rich in tTG (ECM/TG3-tet), or in the presence of 
tet, to inhibit tTG overexpression and deposit a ECM with background levels of tTG 
(ECM/TG3+tet). Cells were then removed by 5 mM EDTA in PBS, and the remaining 
matrices used to measure the attachment of wild-type Swiss 3T3 fibroblasts, pre-
incubated with increasing concentrations of RGD peptide (30-100 µg/ml). RGD-
independent adhesion was also tested on ECM/TG3+tet supplemented with purified tTG 
(20 µg/ml), which was immobilised as done on purified FN (ECM/TG3+tet plus TG). 
Each point represents the mean number of attached cells ±SD of a representative 
experiment performed in triplicate. (B) Relative levels of tTG in the ECM of cells 
overexpressing tTG (TG3-tet) and with background tTG (TG3+tet). tTG was detected by 
an ELISA-type assay described in the “Experimental Procedures”. Values represent the 
mean ± SD of 6 replicates from a representative experiment. (C) Cross-linking activity of 
tTG in ECM/TG3+tet and ECM/TG3-tet, measured by the incorporation of biotinylated 
cadaverine into FN in culture medium DMEM in the absence (DM) or presence of 5 mM 
DTT (DTT). Data represent the mean ± SD of 3 replicates from a typical experiment. 
 
Figure 9 
Cell attachment to tTG-FN promotes cell survival of tTG-null dermal fibroblasts 
induced to undergo apoptosis by inhibition of RGD-dependent integrin function  
(A) Flow cytometric analysis of apoptosis in tTG-null mouse dermal fibroblasts (MDF-
TG-/-). Cells were seeded in medium containing RGD peptide (100 µg/ml) or DMEM 
only, on FN or tTG-FN for 15 h. As a measure of apoptosis, nuclear fragmentation of 
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both adherent and detached cells was detected by TUNEL and quantified by flow 
cytometry as described in the “Experimental Procedures”. The bar denotes the positive 
region of fragmented nuclei (% apoptotic nuclei), set by the negative standard (n.s.) of 
cells undergoing anoikis and incubated with FITC-dUTP in the absence of the enzyme 
TdT (red histogram). Md, median fluorescence channel.  (B) In situ analysis of nuclear 
fragmentation of MDF-TG-/-. Cells were treated with RGD peptide and incubated as 
described in A. After 15 h and 30 h growth, the fractions of cells in suspension were 
processed for in situ detection of DNA fragmentation, which was scored by confocal 
fluorescent microscopy as described in the “Experimental Procedures”. Data represent 
the mean number ±SD of apoptotic cells/well from a typical experiment undertaken in 
triplicate. Total cells analysed, ~450 and ~400 at 15 h and 30 h, respectively. Bar 10 µM. 
(C) Cell viability assay of MDF-TG-/-. Cells were grown in medium containing RGD or 
control RAD peptide (100 µg/ml) on FN or tTG-FN for 15 h, as described above. Cell 
viability was tested following incubation of cells with XTT. Data represent the mean ± 
SD of a typical experiment performed in quadruplicate. 
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             SUPPLEMENTAL  DATA 
 
Figure S1 
RGD-independent adhesion to tTG-FN of epithelial-like cell line ECV-304 
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Cell attachment (upper graph) and cell spreading (lower graph) on FN and tTG-FN was 
assessed in cells pre-incubated with RGD peptide (100 µg/ml) where indicated, as 
described in legend to Fig. 1, but 4h after seeding cells on FN or tTG-FN. Data were 
acquired and expressed as percentage of control value on FN as described in legend to 
Fig. 1 and represent one of two typical experiments, each undertaken in quadruplicate. 
Mean attachment values ±SD on FN control were 400±27; mean percentage values of 
spread cells on FN control were 87±9.  Total cells analysed in control were ~1600. 
